# NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy

> **NCT04112641** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Donna Hammond, PhD** · enrollment: 48 (estimated)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DRUG:** Nicotinamide riboside
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT04112641
- **Lead sponsor:** Donna Hammond, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-19
- **Primary completion:** 2026-06-28
- **Final completion:** 2026-07-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04112641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04112641, "NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04112641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*